Business Context and Reporting Period
Company: GlaxoSmithKline plc (GSK)
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: August 30, 2018
Purpose: Announcement of provisional dividend dates for the fourth quarter (Q4) of 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of corporate action regarding dividends.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document outlines the schedule for the Q4 2018 final dividend.
Guidance, Outlook, and Corporate Actions
Dividend Schedule (Q4 2018 Final):
- Results Announcement Date: Wednesday, February 6, 2019
- Ex-Dividend Date: Thursday, February 21, 2019
- Record Date: Friday, February 22, 2019
- Last Date for DRIP Elections: Thursday, March 21, 2019
- Payment Date: Thursday, April 11, 2019
Note: These dates are indicative and may be subject to change.
Investor Verification Checklist
- Verify the final dividend amount per share in the upcoming Q4 2018 results announcement (scheduled for February 6, 2019).
- Confirm if the indicative dates listed above remain unchanged prior to the ex-dividend date.
- Review the full Q4 2018 financial results for revenue, profit, and cash flow data not included in this 6-K filing.